Eli Lilly CFO leaves after "exhibiting poor judgment"
Josh Smiley, CFO at Eli Lilly, leaves the company after a having "exhibited poor judgment" in a relationship to a colleague, according to the US pharmaceutical giant in a Tuesday announcement. His replacement has been instated.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Eli Lilly's Chief Financial Officer Josh Smiley steps down from Eli Lilly following accusations of an inappropriate relationship between him and an employee, according to a Tuesday press release.
All of Medtech firm Ambu’s products already live up to the new EU rules for medical devices, something the firm attributes to a good sense of how much effort living up to the new legislation would require.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.